SMAD3 Polyklonaler Antikörper

SMAD3 Polyklonal Antikörper für ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human und mehr (2)

Anwendung

WB, ELISA

Konjugation

Unkonjugiert

Publikationen

6

Kat-Nr. : 51145-1-AP

Synonyme

hMAD 3, hSMAD3, HSPC193, HsT17436, JV15 2, MAD homolog 3, Mad3, MADH3, Mothers against DPP homolog 3, SMAD 3, SMAD family member 3, SMAD3

---

Galerie der Validierungsdaten

• 

  WB analysis of HEK-293 using 51145-1-AP

  HEK-293 cells were subjected to SDS PAGE followed by western blot with 51145-1-AP (SMAD3 antibody) at dilution of 1:500 incubated at room temperature for 1.5 hours.

• 

  IHC staining of human breast cancer using 51145-1-AP

  Immunohistochemical analysis of paraffin-embedded human breast cancer using 51145-1-AP (SMAD3 antibody) at dilution of 1:50 (under 10x lens).

• 

  IHC staining of human breast cancer using 51145-1-AP

  Immunohistochemical analysis of paraffin-embedded human breast cancer using 51145-1-AP (SMAD3 antibody) at dilution of 1:50 (under 40x lens).

• 

  IHC staining of human breast cancer using 51145-1-AP

  Immunohistochemical analysis of paraffin-embedded human breast cancer using 51145-1-AP (SMAD3 antibody) at dilution of 1:50 (under 10x lens).

• 

  IHC staining of human breast cancer using 51145-1-AP

  Immunohistochemical analysis of paraffin-embedded human breast cancer using 51145-1-AP (SMAD3 antibody) at dilution of 1:50 (under 40x lens).

• 

  IHC staining of human colon cancer using 51145-1-AP

  Immunohistochemical analysis of paraffin-embedded human colon cancer using 51145-1-AP (SMAD3 antibody) at dilution of 1:50 (under 40x lens).

• 

  IHC staining of human colon cancer using 51145-1-AP

  Immunohistochemical analysis of paraffin-embedded human colon cancer using 51145-1-AP (SMAD3 antibody) at dilution of 1:50 (under 10x lens).

---

Geprüfte Anwendungen

Empfohlene Verdünnung

Anwendung	Verdünnung
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Veröffentlichte Anwendungen

• WB: See 6 publications below

Produktinformation

51145-1-AP bindet in WB, ELISA SMAD3 und zeigt Reaktivität mit human

• Getestete Reaktivität: human
• In Publikationen genannte Reaktivität: human, Maus, Ratte
• Wirt / Isotyp: Kaninchen / IgG
• Klonalität: Polyklonal
• Typ: Antikörper
• Immunogen: Peptid
• Vollständiger Name: SMAD family member 3
• Berechnetes Molekulargewicht: 48 kDa
• GenBank-Zugangsnummer: BC050743
• Gene symbol: SMAD3
• Gene ID (NCBI): 4088
• Konjugation: Unkonjugiert
• Form: Liquid
• Reinigungsmethode: Antigen-Affinitätsreinigung
• Lagerungspuffer: PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3.
• Lagerungsbedingungen: Bei -20℃ lagern. Aliquotieren ist bei -20^oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

SMAD family member 3 (SMAD3), also named Mothers against decapentaplegic homolog 3. Receptor-regulated SMAD (R-SMAD) that is an intracellular signal transducer and transcriptional modulator activated by TGF-beta (transforming growth factor) and activin type 1 receptor kinases. Binds the TRE element in the promoter region of many genes that are regulated by TGF-beta and, on formation of the SMAD3/SMAD4 complex, activates transcription. Also can form a SMAD3/SMAD4/JUN/FOS complex at the AP-1/SMAD site to regulate TGF-beta-mediated transcription. Has an inhibitory effect on wound healing probably by modulating both growth and migration of primary keratinocytes and by altering the TGF-mediated chemotaxis of monocytes. This effect on wound healing appears to be hormone-sensitive. Regulator of chondrogenesis and osteogenesis and inhibits early healing of bone fractures (By similarity). Positively regulates PDPK1 kinase activity by stimulating its dissociation from the 14-3-3 protein YWHAQ which acts as a negative regulator.The observed molecular weight of SMAD3 is about 48 kDa.

Publikationen

Species	Application	Title
mouse	WB	J Ethnopharmacol; Yishen Tongluo formula alleviates diabetic kidney disease through regulating Sirt6/TGF-β1/Smad2/3 pathway and promoting degradation of TGF-β1; Authors - Xiaowei Zhang
human	WB	Biomed Res Int; Multifunctional Drug-Loaded Phase-Change Nanoparticles Inhibit the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Affecting the Activity of Activated Hepatic Stellate Cells; Authors - Xiaomeng Zou
rat	WB	Dis Markers; Pyrrosia petiolosa Extract Ameliorates Ethylene Glycol-Induced Urolithiasis in Rats by Inhibiting Oxidative Stress and Inflammatory Response; Authors - Fangmin Zhou
rat	WB	Heliyon; Benzylisoquinoline alkaloids inhibit lung fibroblast activation mainly via inhibiting TGF-β1/Smads and ERK1/2 pathway proteins; Authors - Hui-Li Ren
human	WB	Pediatr Surg Int; Circular RNA MTCL1 targets SMAD3 by sponging miR-145-5p for regulation of cell proliferation and migration in Hirschsprung's disease; Authors - Wang Chen
human	WB	Int J Biol Sci; Hypoxia-driven TNS4 fosters HNSCC tumorigenesis by stabilizing integrin α5β1 complex and triggering FAK-mediated Akt and TGFβ signaling pathways; Authors - Xinyuan Zhao